Related Experiment Videos
[Nitroglycerin also as a broncholytic]
Abstract:
0,8 mg nitroglycerin administered sublingually to 10 patients with asthma bronchiale and chronic obstructive pulmonary disease effects a reduction of airway resistance up to 21% in the second and fifth minute. Even one hour after application the oscillatory resistance (Ros) is 15% lower than at the beginning. In the same patients 0,4 mg inhaled fenoterol has a stronger effect (-30%). After intravenous administration of nitroglycerin (2,5 mg/h) over 15 minutes there is a significant decrease of the plethysmographic measured resistance (Rt) (-23%), an increase of the vital capacity and a decrease of the residual volume. Side effects are a small reduction of pO2 and blood pressure and an increase of heart rate. Orthostatic disturbances may occur. The venous lactate concentration does not change. The investigation shows that patients with obstructive airway disease may benefit from the application of nitroglycerin.
Insights
Nitroglycerin reduced airway resistance in patients with obstructive airway diseases. This study suggests potential benefits of nitroglycerin for managing conditions like asthma and COPD.
Area of Science:
- Pulmonary Medicine
- Pharmacology
Context:
- Asthma bronchiale and chronic obstructive pulmonary disease (COPD) are characterized by increased airway resistance.
- Current treatments may not fully alleviate symptoms for all patients.
Purpose:
- To investigate the effects of nitroglycerin on airway resistance in patients with obstructive airway diseases.
- To compare nitroglycerin's efficacy with inhaled fenoterol.
Summary:
- Sublingual nitroglycerin (0.8 mg) reduced airway resistance by up to 21% in asthma and COPD patients, with sustained effects for one hour.
- Intravenous nitroglycerin (2.5 mg/h) also significantly decreased airway resistance (-23%) and improved lung volumes.
- Fenoterol (0.4 mg inhaled) demonstrated a stronger bronchodilator effect (-30%) compared to sublingual nitroglycerin.
Impact:
- Nitroglycerin may offer a therapeutic benefit for patients suffering from obstructive airway diseases.
- Further research could explore optimal nitroglycerin dosing and administration routes for respiratory conditions.